Skip to Main Content

Paper Details

Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the CEFCID Trial.
Oncol Res Treat
1
2022
Author NameAffiliation
Peter MartusInstitute for Clinical Epidemiology and Applied Biometry, University of Tuebingen
  • 1 - 1

Datasets

Release 1.2